17 1 General Introduction References 1. World Health Organisation. Tuberculosis (TB): Key Facts [Internet]. Geneva: WHO; 2023 Nov [cited 2023 Nov 29]. Available from: https://www.who.int/publications/m/item/global-tuberculosisreport-factsheet-2023 2. Dheda K, Perumal T, Moultrie H, Perumal R, Esmail A, Scott AJ, et al. The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions. Lancet Respir Med. 2022 Jun;10(6):603–22. 3. Zimmer AJ, Klinton JS, Oga-Omenka C, Heitkamp P, Nyirenda CN, Furin J, et al. Tuberculosis in times of COVID-19. J Epidemiol Community Health [Internet]. 2022 Mar 1 [cited 2023 Oct 18];76(3):310–6. Available from: https://jech.bmj.com/content/76/3/310 4. World Health Organisation. Global Tuberculosis Report 2022 [Internet]. Geneva: WHO; 2022 [cited 2023 Sep 30]. Available from: https://www.who.int/teams/global-tuberculosis-programme/tbreports/global-tuberculosis-report-2022 5. World Health Organisation. WHO global lists of high-burden countries for TB, multidrug/ rifampicin-resistant TB (MDR/RR-TB) and TB/HIV, 2021–2025. [Internet]. Geneva: WHO; 2021 [cited 2023 Oct 1]. Available from: https://www.who.int/news/item/17-06-2021-who-releasesnew-global-lists-of-high-burden-countries-for-tb-hiv-associated-tb-and-drug-resistant-tb 6. Schmidt CW. Linking TB and the Environment: An Overlooked Mitigation Strategy. Environ Health Perspect [Internet]. 2008 Nov [cited 2023 Oct 1];116(11):A478–85. Available from: https://www. ncbi.nlm.nih.gov/pmc/articles/PMC2592293/ 7. Narasimhan P, Wood J, MacIntyre CR, Mathai D. Risk Factors for Tuberculosis. Pulm Med [Internet]. 2013 [cited 2023 Oct 1];2013:828939. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3583136/ 8. De Cock KM, Soro B, Coulibaly IM, Lucas SB. Tuberculosis and HIV Infection in Sub-Saharan Africa. JAMA [Internet]. 1992 Sep 23 [cited 2023 Oct 1];268(12):1581–7. Available from: https:// doi.org/10.1001/jama.1992.03490120095035 9. Bruchfeld J, Correia-Neves M, Källenius G. Tuberculosis and HIV coinfection. Cold Spring Harbor perspectives in medicine. 2015;a017871. 10. Pawlowski A, Jansson M, Sköld M, Rottenberg ME, Källenius G. Tuberculosis and HIV Co-Infection. PLOS Pathogens [Internet]. 2012 Feb 16 [cited 2023 Oct 1];8(2):e1002464. Available from: https:// journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1002464 11. Surie D, Borgdorff MW, Cain KP, Click ES, DeCock KM, Yuen CM. Assessing the impact of antiretroviral therapy on tuberculosis notification rates among people with HIV: a descriptive analysis of 23 countries in sub-Saharan Africa, 2010–2015. BMC Infect Dis [Internet]. 2018 Sep 26 [cited 2023 Oct 1];18(1):481. Available from: https://doi.org/10.1186/s12879-018-3387-z 12. Golub JE, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, King BS, et al. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS [Internet]. 2007 Jul 11 [cited 2023 Oct 1];21(11):1441–8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063947/ 13. World Health Organisation. Non communicable diseases: Key Facts [Internet]. Geneva: WHO; 2023 Sep [cited 2023 Sep 30]. Available from: https://www.who.int/news-room/fact-sheets/detail/ noncommunicable-diseases
RkJQdWJsaXNoZXIy MTk4NDMw